Skip to main content
Skip to content
Info Menu
Show — Info Menu
Hide — Info Menu
Loading data...
Investors
Careers
Global locations
Mega Menu
Show — Mega Menu
Hide — Mega Menu
About Danaher
Approach
News
Science
Search
Mobile Top Menu
Show — Mobile Top Menu
Hide — Mobile Top Menu
Search
Mega Menu
Show — Mega Menu
Hide — Mega Menu
Who we are
About Us
Leadership
Our Businesses
What we stand for
Sustainability
DE+I
Our Process
Danaher Business System
Acquisitions
Partnership Initiatives
Suppliers
Mobile Mega Menu
Show — Mobile Mega Menu
Hide — Mobile Mega Menu
About Danaher
Who we are
About Us
Leadership
Our Businesses
What we stand for
Sustainability
DE+I
Approach
Column 1
Our Process
Danaher Business System
Column 2
Acquisitions
Partnership Initiatives
Suppliers
News
Science
Search
Mega Menu Mobile - Top Level
Show — Mega Menu Mobile - Top Level
Hide — Mega Menu Mobile - Top Level
About Danaher
Approach
News
Science
Search
Info Menu
Show — Info Menu
Hide — Info Menu
Loading data...
Investors
Careers
Global locations
Search
Clear
News
News Topic
Topic
Awards
Company
DE&I
Innovation
Partnerships
Sustainability
Sort by
Changed
Order
Ascending
Descending
How we’re supporting the Human Immunome Project
12.04.24
Genedata: Powering Biopharma AI
11.22.24
The future of pathology is digital
06.18.24
Building a virtual 4D cell
11.12.24
Diagnostics innovation: overlooked for too long
11.06.24
Powering a new paradigm for pathology
11.01.24
DBS in Action: Cepheid’s COVID-19 Response
09.25.24
Diagnosing sepsis: Patients need precision
09.13.24
Back to school: the Danaher 2024 reading list
08.27.24
To treat Alzheimer’s, first we must diagnose it
05.03.24
2023 Danaher Summit Highlight: Valuing Diagnostics
06.13.24
2023 Danaher Summit Highlight: Overcoming Barriers
06.11.24
2023 Danaher Summit Highlights: AI and Data
05.30.24
2023 Danaher Summit Highlights: Patient Access
05.16.24
Brain injury diagnostics: A patient’s perspective
05.10.24
Illuminating the future of genomic medicine
02.29.24
Organoids are small. Their future is big.
02.22.24
IDT’s Rolf Turk considers the future of CRISPR
02.08.24
Pagination
Page
1
Page
2
Next page
Next ›
Last page
Last »
See more
Press Releases